These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29461635)

  • 1. Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group.
    Teot LA; Schneider M; Thorner AR; Tian J; Chi YY; Ducar M; Lin L; Wlodarski M; Grier HE; Fletcher CDM; van Hummelen P; Skapek SX; Hawkins DS; Wagers AJ; Rodriguez-Galindo C; Hettmer S
    Cancer; 2018 May; 124(9):1973-1981. PubMed ID: 29461635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic and survival correlates of embryonal rhabdomyosarcoma driven by RAS/RAF mutations.
    Agaram NP; Huang SC; Tap WD; Wexler LH; Antonescu CR
    Genes Chromosomes Cancer; 2022 Mar; 61(3):131-137. PubMed ID: 34755412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcoma.
    Sun W; Chatterjee B; Shern JF; Patidar R; Song Y; Wang Y; Walker RL; Pawel BR; Linardic CM; Houghton P; Hewitt SM; Edelman DC; Khan J; Meltzer PS; Barr FG
    Int J Cancer; 2019 Jun; 144(11):2707-2717. PubMed ID: 30565669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering metabolism in rhabdomyosarcoma.
    Monti E; Fanzani A
    Cell Cycle; 2016; 15(2):184-95. PubMed ID: 26209235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma.
    Karanian M; Pissaloux D; Gomez-Brouchet A; Chevenet C; Le Loarer F; Fernandez C; Minard V; Corradini N; Castex MP; Duc-Gallet A; Blay JY; Tirode F
    Am J Surg Pathol; 2020 May; 44(5):607-616. PubMed ID: 32187044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pax3-fkhr and pax7-fkhr fusion genes impact outcome of alveolar rhabdomyosarcoma in children.
    Kazanowska B; Reich A; Stegmaier S; Békássy AN; Leuschner I; Chybicka A; Koscielniak E
    Fetal Pediatr Pathol; 2007; 26(1):17-31. PubMed ID: 17613043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Heske CM; Chi YY; Venkatramani R; Li M; Arnold MA; Dasgupta R; Hiniker SM; Hawkins DS; Mascarenhas L
    Cancer; 2021 Mar; 127(6):946-956. PubMed ID: 33216382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.
    Seki M; Nishimura R; Yoshida K; Shimamura T; Shiraishi Y; Sato Y; Kato M; Chiba K; Tanaka H; Hoshino N; Nagae G; Shiozawa Y; Okuno Y; Hosoi H; Tanaka Y; Okita H; Miyachi M; Souzaki R; Taguchi T; Koh K; Hanada R; Kato K; Nomura Y; Akiyama M; Oka A; Igarashi T; Miyano S; Aburatani H; Hayashi Y; Ogawa S; Takita J
    Nat Commun; 2015 Jul; 6():7557. PubMed ID: 26138366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group.
    Hingorani P; Missiaglia E; Shipley J; Anderson JR; Triche TJ; Delorenzi M; Gastier-Foster J; Wing M; Hawkins DS; Skapek SX
    Clin Cancer Res; 2015 Oct; 21(20):4733-9. PubMed ID: 26473193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature.
    Yasuda T; Perry KD; Nelson M; Bui MM; Nasir A; Goldschmidt R; Gnepp DR; Bridge JA
    Hum Pathol; 2009 Mar; 40(3):341-8. PubMed ID: 18973919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonality and evolutionary history of rhabdomyosarcoma.
    Chen L; Shern JF; Wei JS; Yohe ME; Song YK; Hurd L; Liao H; Catchpoole D; Skapek SX; Barr FG; Hawkins DS; Khan J
    PLoS Genet; 2015 Mar; 11(3):e1005075. PubMed ID: 25768946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the Children's Oncology Group.
    Pressey JG; Anderson JR; Crossman DK; Lynch JC; Barr FG
    Pediatr Blood Cancer; 2011 Dec; 57(6):930-8. PubMed ID: 21618411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems.
    Kashi VP; Hatley ME; Galindo RL
    Nat Rev Cancer; 2015 Jul; 15(7):426-39. PubMed ID: 26105539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Determinants of Clinical Outcomes in Rhabdomyosarcoma.
    Casey DL; Wexler LH; Pitter KL; Samstein RM; Slotkin EK; Wolden SL
    Clin Cancer Res; 2020 Mar; 26(5):1135-1140. PubMed ID: 31699828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcoma.
    Harel M; Ferrer FA; Shapiro LH; Makari JH
    Urol Oncol; 2016 Feb; 34(2):103-15. PubMed ID: 26519985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling pathways in Rhabdomyosarcoma invasion and metastasis.
    Ramadan F; Fahs A; Ghayad SE; Saab R
    Cancer Metastasis Rev; 2020 Mar; 39(1):287-301. PubMed ID: 31989508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.
    Shern JF; Chen L; Chmielecki J; Wei JS; Patidar R; Rosenberg M; Ambrogio L; Auclair D; Wang J; Song YK; Tolman C; Hurd L; Liao H; Zhang S; Bogen D; Brohl AS; Sindiri S; Catchpoole D; Badgett T; Getz G; Mora J; Anderson JR; Skapek SX; Barr FG; Meyerson M; Hawkins DS; Khan J
    Cancer Discov; 2014 Feb; 4(2):216-31. PubMed ID: 24436047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX3-NCOA2 fusion gene has a dual role in promoting the proliferation and inhibiting the myogenic differentiation of rhabdomyosarcoma cells.
    Yoshida H; Miyachi M; Sakamoto K; Ouchi K; Yagyu S; Kikuchi K; Kuwahara Y; Tsuchiya K; Imamura T; Iehara T; Kakazu N; Hojo H; Hosoi H
    Oncogene; 2014 Dec; 33(49):5601-8. PubMed ID: 24213582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: a report from the children's oncology group.
    Davicioni E; Anderson JR; Buckley JD; Meyer WH; Triche TJ
    J Clin Oncol; 2010 Mar; 28(7):1240-6. PubMed ID: 20124188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.
    Missiaglia E; Williamson D; Chisholm J; Wirapati P; Pierron G; Petel F; Concordet JP; Thway K; Oberlin O; Pritchard-Jones K; Delattre O; Delorenzi M; Shipley J
    J Clin Oncol; 2012 May; 30(14):1670-7. PubMed ID: 22454413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.